CoChat
Sign Up
Cited by 52

The DOI matches its Crossref record.

MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing

Lehti, Kaisa, Rose, Nina F., Valavaara, Sara, Weiss, Stephen J., Keski-Oja, Jorma·2009·Journal of Cell Science
DOI 10.1242/jcs.035279
Open this paper in CoChat — free account

Abstract

At sites of vessel-wall injury, vascular smooth muscle cells (VSMCs) can dedifferentiate to express an invasive and proliferative phenotype, which contributes to the development of neointimal lesions and vascular disorders. Herein, we demonstrate that the loss of the VSMC differentiated phenotype, as the repression of contractile-protein expression, is correlated with a dramatic upregulation of the membrane-anchored matrix metalloproteinase MT1-MMP (also known as MMP14 and membrane-type 1 matrix metalloproteinase). Matrix metalloproteinase (MMP) inhibitors or MT1-MMP deficiency led to attenuated VSMC dedifferentiation, whereas the phenotypic switch was re-engaged following the restoration of MT1-MMP activity in MT1-MMP–/– cells. MT1-MMP-dependent dedifferentiation was mediated by the PDGF-BB–PDGFRβ pathway in parallel with the proteolytic processing of the multifunctional LDL receptor-related protein LRP1 and the dynamic internalization of a PDGFRβ–β3-integrin–MT1-MMP–LRP1 multi-component complex. Importantly, LRP1 silencing allowed the PDGF-BB-induced dedifferentiation program to proceed in the absence of MT1-MMP activity, supporting the role of unprocessed LRP1 as a gatekeeper of VSMC differentiation. Hence, MT1-MMP and LRP1 serve as a new effector–target-molecule axis that controls the PDGF-BB–PDGFRβ-dependent VSMC phenotype and function.

Overview

Integrity signals

Registry

Crossref · 10.1242/jcs.035279

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 47

  1. Apte, S. S., Fukai, N., Beier, D. R. and Olsen, B. R. (1997). The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J. Biol. Chem.272, 25511-25517. · DOI
  2. Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E. and Reidy, M. A. (1994). Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res.75, 539-545. · DOI
  3. Boucher, P. and Gotthardt, M. (2004). LRP and PDGF signaling: a pathway to atherosclerosis. Trends Cardiovasc. Med.14, 55-60. · DOI
  4. Boucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G. and Herz, J. (2002). Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low Density lipoprotein receptor-related protein in caveolae. J. Biol. Chem.277, 15507-15513. · DOI · Paper page
  5. Boucher, P., Gotthardt, M., Li, W. P., Anderson, R. G. and Herz, J. (2003). LRP: role in vascular wall integrity and protection from atherosclerosis. Science300, 329-332. · DOI
  6. Chamley-Campbell, J. H., Campbell, G. R. and Ross, R. (1981). Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell Biol.89, 379-383. · DOI
  7. Chen, C. N., Li, Y. S., Yeh, Y. T., Lee, P. L., Usami, S., Chien, S. and Chiu, J. J. (2006). Synergistic roles of platelet-derived growth factor-BB and interleukin-1beta in phenotypic modulation of human aortic smooth muscle cells. Proc. Natl. Acad. Sci. USA103, 2665-2670. · DOI
  8. Deryugina, E. I., Bourdon, M. A., Jungwirth, K., Smith, J. W. and Strongin, A. Y. (2000). Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int. J. Cancer86, 15-23. · DOI
  9. Dollery, C. M. and Libby, P. (2006). Atherosclerosis and proteinase activation. Cardiovasc. Res.69, 625-635. · DOI
  10. Filippov, S., Koenig, G. C., Chun, T. H., Hotary, K. B., Ota, I., Bugge, T. H., Roberts, J. D., Fay, W. P., Birkedal-Hansen, H., Holmbeck, K. et al. (2005). MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J. Exp. Med.202, 663-671. · DOI
  11. Galvez, B. G., Matias-Roman, S., Yanez-Mo, M., Sanchez-Madrid, F. and Arroyo, A. G. (2002). ECM regulates MT1-MMP localization with beta1 or alphavbeta3 integrins at distinct cell compartments modulating its internalization and activity on human endothelial cells. J. Cell Biol.159, 509-521. · DOI
  12. Haas, T. L., Stitelman, D., Davis, S. J., Apte, S. S. and Madri, J. A. (1999). Egr-1 mediates extracellular matrix-driven transcription of membrane type 1 matrix metalloproteinase in endothelium. J. Biol. Chem.274, 22679-22685. · DOI
  13. Hayashi, K., Takahashi, M., Kimura, K., Nishida, W., Saga, H. and Sobue, K. (1999). Changes in the balance of phosphoinositide 3-kinase/protein kinase B (Akt) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J. Cell Biol.145, 727-740. · DOI
  14. Hedin, U., Bottger, B. A., Forsberg, E., Johansson, S. and Thyberg, J. (1988). Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J. Cell Biol.107, 307-319. · DOI
  15. Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S. and Spiegel, S. (2001). Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science291, 1800-1803. · DOI
  16. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I. et al. (1999). MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell99, 81-92. · DOI · Paper page
  17. Holmbeck, K., Bianco, P., Yamada, S. and Birkedal-Hansen, H. (2004). MT1-MMP: a tethered collagenase. J. Cell. Physiol.200, 11-19. · DOI
  18. Hotary, K., Li, X. Y., Allen, E., Stevens, S. L. and Weiss, S. J. (2006). A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev.20, 2673-2686. · DOI
  19. Itoh, Y. and Seiki, M. (2006). MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol.206, 1-8. · DOI
  20. Kawai-Kowase, K. and Owens, G. K. (2007). Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol., Cell. Physiol.292, C59-C69. · DOI
  21. Koyama, H., Raines, E. W., Bornfeldt, K. E., Roberts, J. M. and Ross, R. (1996). Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell87, 1069-1078. · DOI
  22. Lehti, K., Lohi, J., Valtanen, H. and Keski-Oja, J. (1998). Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem. J.334, 345-353. · DOI
  23. Lehti, K., Valtanen, H., Wickstrom, S. A., Lohi, J. and Keski-Oja, J. (2000). Regulation of membrane-type-1 matrix metalloproteinase activity by its cytoplasmic domain. J. Biol. Chem.275, 15006-15013. · DOI · Paper page
  24. Lehti, K., Allen, E., Birkedal-Hansen, H., Holmbeck, K., Miyake, Y., Chun, T. H. and Weiss, S. J. (2005). An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. Genes Dev.19, 979-991. · DOI
  25. Lijnen, H. R. (2003). Metalloproteinases in development and progression of vascular disease. Pathophys. Haemost. Thromb.33, 275-281. · DOI
  26. Lijnen, H. R., Van Hoef, B., Lupu, F., Moons, L., Carmeliet, P. and Colleen, D. (1998). Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler. Thromb. Vasc. Biol.18, 1035-1045. · DOI
  27. Lillis, A. P., Mikhailenko, I. and Strickland, D. K. (2005). Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemost.3, 1884-1893. · DOI
  28. Liu, P., Ying, Y., Ko, Y. G. and Anderson, R. G. (1996). Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem.271, 10299-10303. · DOI
  29. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V. M. and Keski-Oja, J. (1996). Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem.239, 239-247. · DOI
  30. Loukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M. M., Loukinov, D., Ulery, P. G., Mikhailenko, I., Lawrence, D. A. and Strickland, D. K. (2002). Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function betwenn LRP and the PDGF. J. Biol. Chem.277, 15499-15506. · DOI
  31. May, P., Reddy, Y. K. and Herz, J. (2002). Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem.277, 18736-18743. · DOI · Paper page
  32. Owens, G. K., Kumar, M. S. and Wamhoff, B. R. (2004). Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev.84, 767-801. · DOI
  33. Page-McCaw, A., Ewald, A. J. and Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nat. Rev. Mol. Cell. Biol.8, 221-233. · DOI · Paper page
  34. Peterson, T. E., Guicciardi, M. E., Gulati, R., Kleppe, L. S., Mueske, C. S., Mookadam, M., Sowa, G., Gores, G. J., Sessa, W. C. and Simari, R. D. (2003). Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler. Thromb. Vasc. Biol.23, 1521-1527. · DOI
  35. Raines, E. W. (2004). PDGF and cardiovascular disease. Cytokine Growth Factor Rev.15, 237-254. · DOI
  36. Rajavashisth, T. B., Xu, X. P., Jovinge, S., Meisel, S., Xu, X. O., Chai, N. N., Fishbein, M. C., Kaul, S., Cercek, B., Sharifi, B. et al. (1999). Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation99, 3103-3109. · DOI
  37. Rozanov, D. V., Hahn-Dantona, E., Strickland, D. K. and Strongin, A. Y. (2004). The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J. Biol. Chem.279, 4260-4268. · DOI · Paper page
  38. Schneider, F., Sukhova, G. K., Aikawa, M., Canner, J., Gerdes, N., Tang, S. M., Shi, G. P., Apte, S. S. and Libby, P. (2008). Matrix-metalloproteinase-14 deficiency in bone-marrow-derived cells promotes collagen accumulation in mouse atherosclerotic plaques. Circulation117, 931-939. · DOI · Paper page
  39. Schneller, M., Vuori, K. and Ruoslahti, E. (1997). Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J.16, 5600-5607. · DOI
  40. Shanahan, C. M., Weissberg, P. L. and Metcalfe, J. C. (1993). Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circulation Res.73, 193-204. · DOI
  41. Sukhova, G. K., Shi, G. P., Simon, D. I., Chapman, H. A. and Libby, P. (1998). Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest.102, 576-583. · DOI
  42. Takayama, Y., May, P., Anderson, R. G. and Herz, J. (2005). Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta). J. Biol. Chem.280, 18504-18510. · DOI
  43. Tallquist, M. and Kazlauskas, A. (2004). PDGF signaling in cells and mice. Cytokine Growth Factor Rev.15, 205-213. · DOI
  44. Thyberg, J. and Hultgardh-Nilsson, A. (1994). Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res.276, 263-271. · DOI
  45. Zempo, N., Kenagy, R. D., Au, Y. P., Bendeck, M., Clowes, M. M., Reidy, M. A. and Clowes, A. W. (1994). Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg.20, 209-217. · DOI
  46. Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y. and Tryggvason, K. (2000). Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc. Natl. Acad. Sci. USA97, 4052-4057. · DOI · Paper page
  47. Zhu, Y. and Hui, D. Y. (2003). Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. J. Biol. Chem.278, 36257-36263. · DOI

Cited by

Sorted by citations

Metadata

Authors
Lehti, K., Rose, N. F., Valavaara, S., Weiss, S. J., & Keski-Oja, J.
Venue
Journal of Cell Science
Publisher
The Company of Biologists
Published
2009-01-01
Volume
122
Issue
1
Pages
126-135
ISSN
  • 1477-9137
  • 0021-9533
DOI
10.1242/jcs.035279
Cited by
52
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review